Traditional EEG monitoring takes hours to set up and requires specialist training. The Ceribell Point-of-Care EEG is ready in minutes, monitors continuously, and alerts clinicians the moment a seizure is detected.
Photo source:
ceribell.com
Not all seizures are visible. In intensive care
units and emergency departments, a significant number of patients experiencing
seizures show no outward physical signs. No convulsions. No obvious distress.
Just a brain in crisis that nothing in the room is detecting. Traditional EEG
monitoring, the only tool capable of capturing this activity, requires
specialist equipment, expert setup, and access to a trained neurologist to
interpret the results. In a busy ICU or emergency department where neurologists
are not always immediately available, that process takes time the patient does
not have. Ceribell was built to close that gap entirely.
The Ceribell Point-of-Care EEG system is
designed for rapid setup within minutes by clinicians with minimal training.
Traditional EEG systems require specialist technicians and lengthy preparation
that delays the start of monitoring in time-critical situations. The Ceribell
system removes that barrier, placing continuous brain activity monitoring
directly at the bedside in the ICU, emergency department, neurology ward,
pediatric ICU, and neonatal ICU. Once set up, the system monitors continuously
and streams real-time EEG data to a cloud-based portal that physicians can
access from anywhere, enabling remote neurology review without requiring a
specialist to be physically present at the bedside.
At the core of the Ceribell system is Clarity
AI, the first FDA-cleared instantaneous bedside alert system for suspected
status epilepticus in adults and continuous seizures in neonates and pediatric
patients. Status epilepticus is a prolonged seizure state that causes rapid and
irreversible brain damage if not identified and treated quickly. Clarity AI
monitors the EEG signal continuously and alerts the clinical team the moment it
detects suspected continuous seizures or status epilepticus, providing 24-hour-a-day,
seven-day-a-week surveillance that no human team can replicate at scale. The
signal quality delivered by the Ceribell system is equivalent to conventional
EEG, validated in peer-reviewed clinical research. A seizure burden display
tracks the intensity of seizure activity over time and provides real-time
feedback on whether medication is having the intended effect.
The Ceribell system covers adults, pediatric
patients, and neonates through separate FDA-cleared algorithms and dedicated
portal views designed around the specific monitoring needs of each population.
EEG labeling throughout each recording improves reading efficiency for
neurologists reviewing remotely. The seizure burden trend display supports
effective seizure management and gives clinicians a clear picture of how the
patient is responding to treatment in real time, reducing the uncertainty that
has historically made seizure management in the ICU a reactive rather than a
proactive process.
Please subscribe to have unlimited access to our innovations.